Sarepta Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Sarepta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $27M | 276k | 96.44 |
| 2023-09-30 | $29M | 237k | 121.22 |
| 2023-06-30 | $25M | 216k | 114.52 |
| 2023-03-31 | $27M | 194k | 137.83 |
| 2022-12-31 | $21M | 163k | 129.58 |
| 2022-09-30 | $11M | 101k | 110.74 |
| 2022-06-30 | $8.8M | 118k | 74.96 |
| 2022-03-31 | $12M | 153k | 78.13 |
| 2021-12-31 | $5.6M | 63k | 90.03 |
| 2021-09-30 | $4.3M | 47k | 92.44 |
| 2021-06-30 | $2.6M | 34k | 77.74 |
| 2021-03-31 | $6.5M | 87k | 74.53 |
| 2020-12-31 | $12M | 72k | 170.37 |
| 2020-09-30 | $9.4M | 67k | 140.43 |
| 2020-06-30 | $12M | 77k | 160.33 |
| 2020-03-31 | $8.2M | 84k | 97.82 |
| 2019-12-31 | $11M | 87k | 128.54 |
| 2019-09-30 | $16M | 205k | 75.30 |
| 2019-06-30 | $17M | 109k | 151.95 |
| 2019-03-31 | $9.6M | 80k | 120.00 |
| 2018-12-31 | $9.3M | 85k | 109.11 |
| 2018-09-30 | $10M | 62k | 161.44 |
| 2018-06-30 | $12M | 91k | 132.16 |
| 2018-03-31 | $8.0M | 108k | 74.10 |
| 2017-12-31 | $5.1M | 92k | 55.54 |
| 2017-09-30 | $6.7M | 148k | 45.36 |
| 2017-06-30 | $10M | 309k | 33.71 |
| 2017-03-31 | $2.8M | 95k | 29.60 |
| 2016-12-31 | $5.3M | 192k | 27.43 |
| 2016-09-30 | $29M | 465k | 61.41 |
| 2016-06-30 | $17M | 926k | 18.75 |
| 2016-03-31 | $2.0M | 99k | 20.00 |
| 2015-12-31 | $8.2M | 213k | 38.58 |
| 2015-09-30 | $3.7M | 116k | 32.09 |
| 2015-03-31 | $1.5M | 109k | 13.75 |